Ironwood Pharmaceuticals Inc. (NASDAQ:IRWD)

There are currently no videos for this stock.
To request coverage of this stock, please click the green request video box on the right.
Bands Volume 200 SMA 50 SMA 20 SMA Videos Alerts Articles Events
IRWD Weekly Chart

Old Forum Content for IRWD

Make a Forum Post
Become a member to view recent forum posts. Already a member? Sign in here.
Loading...
  • scottrades: $IRWD popping on good volume. Chatter about an $ABBV takeover.
  • joelsg1: @scottrades $IRWD $ABBV $IRWD Main consumer drug Linzess flat sales despite massive ad spend and not best in class; Trulance much better owned by $BHC. So don't trust that rumor.
  • greenpatrol: $IRWD triggered an inside month and up at 19.39. Long at 19.40
  • Danzguy: @gwenzee $ALG $IRWD #OT I'm continually haunted by the KY Jelly advertisements on overnight news shows. Does that count as annoying?
  • gwenzee: @Danzguy $ALG $IRWD #OT I missed those.
  • bigbartabs: @gwenzee $ALG $IRWD ... and all this time I thought IBS was an accounting firm.
  • gwenzee: @Woodman @DeBeers @Bigbartabs $ALG $IRWD Let the celebration begin!!! April is IBS (irritable bowel syndrome)awareness month. "Yes. Linzess" - New ad campaign shows 2 people on the commode. Shortly thereafter they are seen with a smile and fist pump to show "universal feeling of exhilaration of relief after finding constipation relief" according to VP of gastroenterology, Aimee Lenar. IMO this is crossing the line in advertising. But, with that being said, can't wait for the next Viagra ad. Just call me a dirty old woman. Can I say NP?
  • gwenzee: @bigbartabs $ALG $IRWD Guess it depends on where you do your taxes
  • bigbartabs: @gwenzee $ALG $IRWD ... or where you feel taxed.
  • JJT1: $IRWD Big green candle b/o above upper BB
  • woodman: @gwenzee $JUNO $RXDX #Biotech $BLUE up ~7% in the afterhours. Biotech will jump tomorrow. Fwiw, GS sees these as having the highest M&A probability in biopharma (some of these are perennial buyout names): $AVXS $SAGE $SRPT $BMRN $BLUE $BMPC $CLVS $INCY $IPXL $PCRX $PTLA $ACAD $GWPH $BMY $IRWD $AGIO $ALKS $JUNO $SGEN $MNTA $BIVV.
  • gwenzee: @woodman $JUNO $RXDX $BLUE $AVXS $SAGE $SRPT $BMRN $BMPC $CLVS $INCY $IPXL $PCRX $PTLA $ACAD $GWPH $BMY $IRWD $AGIO $ALKS $SGEN $MNTA $BIVV #Biotech Thanks for the info. Previously held JUNO, BLUE, SRPT. Currently hold only INCY.
  • JJT1: $IRWD Also on an oversold buy list. Maybe watch for stochastic cross next week? JPM cut to neutral but green today, Hammer reversal at 200 day on monday? np
  • geotheo: @champ $AGN - Ironwood Pharmaceuticals, Inc. $IRWD and Allergan plc $AGN announced encouraging top-line data from a phase IIb study on the colonic release-1 (CR1) formulation of Linzess (linaclotide) for the treatment of adult patients suffering from irritable bowel syndrome with constipation (IBS-C). In a separate press release, the companies reported top-line data from the same phase IIb study on a second formulation — the colonic release-2 (CR2) formulation of Linzess.
  • champ: @geotheo $AGN $IRWD --- Thanks for the Info....
  • geotheo: @champ $AGN $IRWD - Irritable bowel syndrome with constipation (IBS-C). That sounds opposite of I would assume IBS would give you.
  • JJT1: @woodman $GWPH $NVAX Thanks for info. I also feel hesitant to do anything and I have NP in this now. I am getting ready to camp, fish and won't be in market next week. Leave you and other's with $IRWD, also came up in P&F DT B/O scan and sales doubling last few years...
  • woodman: @JJT1 $GWPH $NVAX $IRWD Have a great time fishing. I'm jealous. :-)
  • Aragorn: @JJT1 $GWPH $NVAX $IRWD GWPH forming inside day and inside week. Day triggers week this is gong to get real interestingMonday. Either way inside week and potential signal there all week long
  • Bridget: Notes: Breakouts on Volume: $OPHT, $CSX, $SGYP, $GIMO, $GHL, $JBL, $STM, $SUPN, $CEMP. $AMTD, $NH, $FNFV, Working: $GKOS, $CWEI, $FNSR, $LOGM, $BABA, $ATVI, $IRWD, $BHE - nice move off the 50MA $MSCC - almost breakout $ILMN - almost breakout $INTC - back up near the high $SWKS - making a nice move with AAPL $PBR - looking toppy, have alert set at the 50MA for a breakdown $PNRA - looking toppy, needs to recover the 200MA $CHU - huge volume today, weekly chart is turning up $JWN - showing a nice move after the flag pattern $CNX - this is broken, get out $GPRO - nice move off support with volume $SBUX - at the bottom of the range, could be a good low risk buy point $ABX - showing support at $17
  • moneyHoHo: $IRWD strong
  • dmgrevas: $IRWD - Looks like its breaking out of a pennant. Any comments?
  • Tim S: Notable earnings before Tuesday's open $AMTD, $BHI, $COL, $DAL, $EDU, $FRX, $HAL, $IRWD, $JNJ, $PETS, $RF, $SAP, $SNV, $TRV, $VZ
  • Tim S: Notable earnings before Tuesday's open $AKS, $ARMH, $CIT, $CNC, $COH, $CSL, $DAL, $DD, $EMC, $ENTG, $FCX, $FMER, $FRX, $GNTX, $HOG, $IDXX, $IRWD, $ITW, $KMB, $LMT, $LRY, $LXK, $MHFI, $NUS, $NVS, $PCH, $PII, $PNR, $R, $RAI, $RF, $RSH,SIAL, $SNV, $STT, $TRV, $UTX, $WAT, $WHR, WIT
  • woodman: $IRWD - I suggest that folks watch this one. It completed a nice W, which took it just barely above the 200 day. Then it pulled back just under the 200 day, but the 8 dEMA is serving as support. It is now bouncing above/below/at the 200 day. A move above yesterday's high I think would signal that it is going up from here. The 8 dEMA should cross over the 200 day shortly. That's a good sign. Volume has been above average 8 of the last 9 days. No position, but that could change shortly.
  • woodman: $IRWD - not doing as I hoped/expected. It did not reach my buy signal which was a move above yesterday's high. Instead, it has reversed again below the 200 day. That's why we wait and why I didn't buy. As @DAN said last night, we wait and react.
  • woodman: $IRWD - completed a "W" pattern with a close just above the 200 day yesterday. Today, as I suspected, it has moved lower (below the 200) and appears to be testing this area. I would think that if it can move above yesterday's high, it will have some more room for a decent run. I am looking at 9/11's low as what needs to hold to think it could make this move.
  • Poppy: EARNING season is upon us, here's a short list from SA: Notable earnings before today's [4/23] open: $ACI, $AKS, $AOS, $APD, $ARMH, $CIT, $CNC, $COH, $DAL, $DD, $DFS, $EAT, $ECA, $FMER, $FRX, $GCI, $GNTX, $IDXX, $IIVI, $IR, $IRWD, $ITW, $JCI, $JNS, $LCC, $LECO, $LMT, $LXK, $MOLX, $PCAR, $PCH, $PII, $PMT, $PNR, $R, $RAI, $RF, $RSH, $SNV, $ST, $TRV, $UTX, $WAT, $XRX Notable earnings after today's close: $AAPL, $ACC, $AMGN, $AWAY, $BCR, $BRCM, $CREE, $DV, $EW, $FBC, $FTI, $HA, $HBI, $HLIT, $HTS, $IRBT, $ITC, $JNPR, $LIFE, $NBR, $NFX, $NSC, $OI, $OII, $OMI, $PACB, $PLCM, $PNRA, $RFMD, $RHI, $T, $UIS, $USNA, $VMW, $WRB, $YUM, $ZIXI Any of these one of yours? @poppy
  • Tricia: IRWD: Cambridge, MA-based Ironwood ($IRWD) cleared a major milestone in its development this morning, winning an FDA approval for linaclotide and paving the way for its big leap into commercialization. Regulators OK'd linaclotide--now dubbed Linzess- ...
  • gold2stocks: ...
    $IRWD
    Ironwood Pharmaceuticals downgraded at Wedbush
    $IRWD was downgraded to Underperform from Outperform, Wedbush said. $8 price target. Updated launch expenses leads to significant anticipated funding gap.

    $JBL
    Jabil Circuit downgraded a ...
  • gold2stocks: ...
    $IRWD
    Ironwood Pharmaceuticals downgraded at Cantor
    $IRWD was downgraded to Sell, Cantor Fitzgerald said. Valuation call, based on a $10 price target.

    $MRO
    Marathon Oil downgraded at Deutsche
    $MRO was downgraded from Buy to Hold, Deutsche Ban ...
Visit the Trading Forum to join in the discussion.
Stock Price $8.71
Change 1.04%
Volume 2,699,380

Ironwood Pharmaceuticals, Inc. is an entrepreneurial pharmaceutical company that discovers, develops and intends to commercialize differentiated medicines that improve patients' lives.

Request Video of IRWD
Already a member? Sign in here.
Past Month

Leading Peers

Past Month

Lagging Peers

Dan Fitzpatrick

Stock Market Mentor gives you EVERYTHING you need to succeed in the market; all in one place. How easy is that? Dan Fitzpatrick and his elite community of traders share trading ideas, strategies and much more. Dan Fitzpatrick--a world class Technical Analyst, trading coach and regular CNBC contributor--gives you access to all of this with a 30 day trial membership for just $7.77. Get started TODAY and start trading better TOMORROW with the following premium content:

  • Nightly video Strategy Sessions with a game plan for tomorrow
  • Got a stock you want Dan to look at? Just ask.
  • Patent pending video alerts instantly delivered to you when one of Dan’s trading signals is triggered. This is not your typical price alert. This is a short video explaining the action you need to take to make money. No more “Woulda, coulda, shoulda”
  • Access to over 90,400 stock analysis videos
  • Access an ever expanding library (90,400) of educational videos that will save you time and make you money

Join a team of friends and traders that have one thing in common; a burning desire to succeed.

Become a Member Today!

Gain immediate access to all our exclusive articles, features, how-to's, discussion group and much more...

Satisfaction Guaranteed!

Your Stock Market Mentor membership comes with a 30 day, no questions asked, 100% money back guarantee!